The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma

Chang-Ki Min1

  • 1Division of Hematology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea.

Insights

Chronic graft-versus-host disease (CGVHD) is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Understanding CGVHD pathogenesis and utilizing validated diagnostic criteria are key to improving patient outcomes.

Area of Science:

  • Immunology
  • Hematology
  • Transplantation Medicine

Background:

  • Chronic graft-versus-host disease (CGVHD) is a significant complication for long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT).
  • CGVHD presents diverse clinical manifestations, posing diagnostic and therapeutic challenges.
  • Current diagnostic recommendations focus on qualitative differences rather than onset time, requiring further validation.

Purpose of the Study:

  • To review recent clinical advancements in CGVHD diagnosis and management.
  • To elucidate the complex pathogenesis of CGVHD, including cellular and cytokine networks.
  • To discuss the role of animal models in developing prevention and treatment strategies for CGVHD.

Main Methods:

  • Review of experimental studies and clinical observations on CGVHD.
  • Analysis of proposed pathophysiological theories for CGVHD, including thymic damage, regulatory T cell deficiencies, auto-antibody production, and profibrotic lesions.
  • Evaluation of insights gained from mouse models of CGVHD.

Main Results:

  • While mechanisms of acute GVHD are better understood, CGVHD biology remains less clear.
  • Four main theories explain CGVHD pathophysiology: thymic damage, Treg deficiency, B-cell auto-antibody production, and profibrotic lesions.
  • Animal models have provided valuable insights but do not fully replicate human CGVHD.

Conclusions:

  • Accurate diagnosis and understanding of CGVHD pathogenesis are crucial for improving outcomes after allo-HSCT.
  • Further validation of new diagnostic criteria is needed.
  • Continued research, including the use of animal models, is essential for developing effective CGVHD prevention and treatment strategies.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...